“…Then, the Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction provides the target product IV (Scheme 1, pathway A) [59][60][61]. Pathway B is designed on the basis of our group investigations on the synthesis of 2,6-bistriazolylpurine derivatives and their application in reactions with N-, S-and P-nucleophiles making use of regioselective S N Ar reactions at C(6) (V→VI→IV, Scheme 1) [11,14,62,63,77,78]. The main advantage of pathway B is a straightforward access to 2,6-diazidopurines V and 2,6-bistriazolylpurines VI due to excellent nucleophilic properties of the azide ion and wellestablished CuAAC reaction.…”